Latest news
Stay up to date
Receive updates on new technology developments, market and industry trends, special events, Mayo Clinic technologies available for licensing, and more.
PR Newswire | August 29, 2022
Fierce Pharma | August 18, 2022
Mayo Clinic News Network | August 15, 2022
Mass Device | August 1, 2022
EXCERPT:Â Mayo Clinic participated, making the Israel-based firm a Mayo Clinic portfolio company.
Business Wire | July 20, 2022
Mayo Clinic News Network | July 19, 2022
Med City News | July 15, 2022
EXCERPT: Anumana was formed by Mayo Clinic and nference, a company that uses unstructured electronic medical records data from medical centers to develop new diagnostics and treatments.
Fierce Biotech | July 14, 2022
Mayo Clinic News Network | June 21, 2022
Fierce Healthcare | June 20, 2022
Mass Devices | May 24, 2022
EXCERPT: The algorithm is Anumana’s second to receive a breakthrough nod, with its low ejection fraction algorithm (developed by Mayo Clinic and licensed by Anumana) garnering approval in 2019, plus FDA emergency use authorization (EUA) for COVID-19 in 2020.
Mayo Clinic News Network | May 23, 2022
Star Tribune | May 17, 2022
EXCERPT:Â The company, an outgrowth of Mayo Clinic, recently raised more money from investors as it seeks new ways to treat cancer
PR Newswire | May 17, 2022
Mayo Clinic News Network | May 2, 2022
EXCERPT:Â Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic effectively identified patients with a weak heart pump.
PR Newswire | April 14, 2022
Star Tribune | February 7, 2022
PR Newswire | January 19, 2022
EXCERPT:Â Pathogenomix, Inc. collaborated with Mayo Clinic on the development of the techniques and data which supported the application for this FDA Breakthrough Device Designation.Â
PR Newswire | January 6, 2022
Globe Newswire | January 4, 2022
Business Wire | January 4, 2022